Stopped: The study was terminated because of the COVID-19 pandemic (Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention).
During adolescence, youth undergo rapid developmental change and in some cases experience increases in worries and fearfulness, although the mechanisms that underlie this change are unclear. Previous studies indicate that heightened Attentional Bias (AB) toward threat-related cues may increase fearfulness, and it may be possible to change AB using a computerized, Attention Bias Modification task (ABM). This study will recruit healthy youth with elevated anxious symptoms to index attentional tendencies toward threat-related stimuli using cutting-edge techniques, and to test the effect of a computerized attention training task in altering attention to threatening cues. The investigators will also examine the role of ABM in changing youth's attention-related resting-state functional connectivity (rsFC), a neural marker of at-rest cognition.
Age range
11 Years – 13 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change from baseline in parent-reported anxious symptoms at 3 weeks follow-up
Timeframe: 3 weeks from baseline (after completing the 3rd weekly training session)
Change from baseline in parent-reported anxious symptoms at 6 weeks follow-up
Timeframe: 6 weeks from baseline (after completing the 6th weekly training session)
Change from baseline in youth self-reported anxious symptoms at 3 weeks follow-up
Timeframe: 3 weeks from baseline (after completing the 3rd weekly training session)
Change from baseline in youth self-reported anxious symptoms at 6 weeks follow-up
Timeframe: 6 weeks from baseline (after completing the 6th weekly training session)